Average Co-Inventor Count = 5.13
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (17 from 3,923 patents)
2. Bristol-myers Squibb Compnay (16 from 3,684 patents)
3. Sloan-kettering Institute for Cancer Research (1 from 512 patents)
4. Novartis Vaccines & Diagnostics, Gmbh (1 from 245 patents)
5. Ideaya Biosciences, Inc. (1 from 12 patents)
35 patents:
1. 12503467 - 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
2. 11912715 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
3. 11453677 - Tricyclic compounds useful to treat orthomyxovirus infections
4. 11098051 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
5. 10858366 - Tricyclic compounds useful to treat orthomyxovirus infections
6. 10537561 - CSF-1R inhibitors for treatment of brain tumors
7. 10160764 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
8. 10112931 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
9. 9688672 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
10. 9434719 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
11. 8957068 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
12. 8778951 - Heteroaryl compounds and their uses
13. 8710048 - 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
14. 8415381 - Heteroaryl compounds and their uses
15. 8329718 - N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions